AKT1 and osteosarcoma: UBE2T promotes the proliferation, migration, and invasion of osteosarcoma cells through positive regulation of the PI3K/Akt signaling pathway, suggesting that UBE2T may serve as an important target in osteosarcoma therapy [78].